SomnoMed (ASX:SOM) Net Income From Continuing Operations : A$-10.51 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is SomnoMed Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. SomnoMed's net income from continuing operations for the six months ended in Dec. 2023 was A$-6.35 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was A$-10.51 Mil.

SomnoMed Net Income From Continuing Operations Historical Data

The historical data trend for SomnoMed's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Net Income From Continuing Operations Chart

SomnoMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Income From Continuing Operations

Get a 7-Day Free Trial

-0.04

-0.44

-1.08

-4.43

-7.87

SomnoMed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial															-2.95	-1.47	-3.70	-4.16	-6.35

SomnoMed Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-10.51 Mil.

SomnoMed (ASX:SOM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (ASX:SOM) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

SOMNF:USA RJV:Germany

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (ASX:SOM) Headlines

No Headlines